Form 4: Director Shirley Brady Acquires Enovis Shares
Statement of Changes in Beneficial Ownership
Enovis Corporation Director Shirley Brady acquired 9,346 shares of common stock on May 19, 2026.
Summary
- Director Shirley Brady acquired 9,346 shares of Enovis Corporation (ENOV) common stock.
- The transaction occurred on May 19, 2026.
- The shares were acquired at a price of $0.00 per share, typically indicating a grant of equity compensation.
- Following this transaction, the reporting person's total beneficial ownership is 110,589 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine regulatory disclosure regarding director compensation.
Positives
- Increased equity stake by a member of the Board of Directors signals alignment with shareholder interests.
Negatives
- None identified.
Risks
- None identified.
Future Outlook
Not applicable as this is a standard insider transaction filing.
Industry Context
StockSavvy.ai notes that director equity acquisitions are standard corporate governance practices intended to align leadership incentives with long-term company performance.
Comparison to Industry Standards
- The acquisition of equity by directors is a common practice across the medical technology and manufacturing sectors to ensure board commitment.
Stakeholder Impact
- Positive signal for shareholders as it reflects director investment in the company.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 05/19/2026 | Date of the equity acquisition transaction. |
| 05/21/2026 | Date the Form 4 was signed and filed. |
Keywords
Enovis, ENOV, Insider Trading, Form 4, Director, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.